Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose tamoxifen for high BPU on MBI
NCT02979301Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Background Parenchymal Uptake at 30 days. Started Mar 2017; status: completed.
02
Drugs
tamoxifen
Beyond the preview
Go deeper on NCT02979301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979301.